Perinatal measles infection and subsequent Crohn's disease

A Ekbom1, A J Wakefield, M Zack

  • 1Cancer Epidemiology Unit, University Hospital, Uppsala, Sweden.

Lancet (London, England)
|August 20, 1994
PubMed

Insights

Measles virus exposure during infancy may increase Crohn's disease risk. This study found more Crohn's disease cases in individuals born during measles epidemics, suggesting a link.

Area of Science:

  • Epidemiology
  • Virology
  • Gastroenterology

Background:

  • The etiology of Crohn's disease remains unknown.
  • Measles virus has been implicated as a potential contributing factor, especially with early-life exposure.
  • Previous studies suggest a correlation between measles epidemics and increased Crohn's disease incidence.

Purpose of the Study:

  • To investigate the association between measles epidemics and the incidence of Crohn's disease.
  • To determine if birth during a measles epidemic increases the risk of developing Crohn's disease.
  • To assess the vulnerability of the perinatal period to measles exposure in relation to Crohn's disease.

Main Methods:

  • Identified individuals diagnosed with Crohn's disease before age 30 in four Swedish counties (1945-1954).
  • Analyzed measles epidemic data and birth records for the study period.
  • Calculated expected vs. observed Crohn's disease and ulcerative colitis cases born in the 3 months following measles epidemic peaks, adjusting for livebirths.

Main Results:

  • A significant excess of Crohn's disease cases (57 observed vs. 39.0 expected) was found in individuals born after measles epidemic peaks (SIR 1.46).
  • The observed number of ulcerative colitis cases (42) was similar to the expected number (46.8).
  • Results indicate a statistically significant association between measles epidemics and subsequent Crohn's disease diagnosis.

Conclusions:

  • The findings strengthen the hypothesis linking measles virus to Crohn's disease.
  • The perinatal period appears to be a critical window of vulnerability for measles exposure concerning Crohn's disease development.
  • Further research is warranted to elucidate the specific mechanisms involved in this association.

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...